Advertisement
UK markets closed
  • NIKKEI 225

    38,405.66
    +470.90 (+1.24%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • CRUDE OIL

    81.55
    -1.08 (-1.31%)
     
  • GOLD FUTURES

    2,297.30
    -60.40 (-2.56%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • Bitcoin GBP

    48,167.39
    -2,240.02 (-4.44%)
     
  • CMC Crypto 200

    1,284.86
    -54.20 (-4.05%)
     
  • NASDAQ Composite

    15,657.82
    -325.26 (-2.04%)
     
  • UK FTSE All Share

    4,430.25
    -4.93 (-0.11%)
     

Availability of Transgene's 2023 Universal Registration Document

Transgene S.A.
Transgene S.A.

TRANSGENE (Paris: TNG) today announced that its Universal registration document for the fiscal year ended December 31, 2023, was submitted to the French stock market authority (Autorité des Marchés financiers – AMF) in ESEF format and registered under the reference D.24-0274.

The 2023 Universal Registration Document is available to the public under the conditions provided by applicable regulations. The document is available on the Company’s website: www.transgene.fr, in the “Investors/Financial information” section and on the AMF website: www.amf-france.org.

It includes:

  • the 2023 annual financial report;

  • the report of the Board of Directors on corporate governance;

  • the statutory auditor’s reports;

  • information on the share buyback program;

  • information related on the auditor’s fees.

ADVERTISEMENT

The universal registration document also includes information on the Company’s environmental and social responsibility.

Contacts

Transgene:
Lucie Larguier
Chief Financial Officer
+33 (0)3 88 27 91 04
investorrelations@transgene.fr

 

Attachment